Exploring GLP-1 Agonists for Weight Management

This chapter explores how GLP-1 agonists, such as liraglutide and semaglutide, aid in weight reduction for those affected by antipsychotic-induced weight gain. It includes insights from clinical trials on their effectiveness, mechanisms, side effects, and the financial challenges patients may face.